[시장보고서]매독 면역 측정 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

매독 면역 측정 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

Syphilis Immunoassay Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

상품코드 : 1624345

리서치사 : Transparency Market Research

발행일 : 2024년 11월

페이지 정보 : 영문 241 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,410,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,765,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 17,119,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

매독 면역측정 진단 시장 - 조사 범위

TMR의 세계 매독 면역 측정 진단 시장에 대한 조사 보고서는 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 이 보고서는 2024년을 기준 연도, 2034년을 예측 연도로 하여 2018년부터 2034년까지 전 세계 매독 면역 측정 진단 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 매독 면역측정 진단 시장의 복합 연간 성장률(CAGR%)도 제시합니다.

이 보고서는 광범위한 1차 조사, KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체와의 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조하여 매독 면역 측정 진단 시장을 추론했습니다, 매독 면역 측정 진단 시장을 추론했습니다.

시장 현황
2023년 시장 매출	5억 4,850만 달러
2034년 시장 매출	9억7,850만 달러
CAGR	5.5%

이 보고서는 세계 매독 면역 측정 진단 시장의 경쟁 환경을 조사했습니다. 세계 매독 면역 측정 진단 시장에서 사업을 운영하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT는 세계 매독 면역 측정 진단 시장 기업의 속성이며, 이 보고서에서 소개합니다.

주요 업계 이벤트
유통업체 상황
Porter의 Five Forces 분석
최종사용자 선호
매독역학 : 지역별/국가별
정부 이니셔티브 : 지역별/국가별
헬스케어 지출 : 지역별/국가별(의료비 총액, 달러/인, 2022년)
PESTEL 분석
베드사이드 검사와 POC가 매독 시장 역학에 미치는 영향
브랜드와 가격 분석
규제 시나리오 : 지역별/국가별
공급망 분석
기술적 진보

제6장 세계 시장 분석과 예측 : 제품별

서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 제품별, 2020년-2034년
- 분석 장비
- 키트 및 시약
시장의 매력 : 제품별

제7장 세계 시장 분석과 예측 : 기술별

서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 기술별, 2020년-2034년
- 화학 발광 어세이(CLIA)
- 효소 면역측정법(ELISA)
- 면역 크로마토그래피 어세이/측면 흐름 분석
- 트레포네이마·파리담라텍스 응집 반응(TPLA)
- 비트레포네이마 응집 어세이
시장의 매력 : 기술별

제8장 세계 시장 분석과 예측 : 검사 유형별

서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 검사 유형별, 2020년-2034년
- 트레포네이마 검사
- 비트레포네이마 검사
시장의 매력 : 검사 유형별

제9장 세계 시장 분석과 예측 : 검사장소별

서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 검사장소별, 2020년-2034년
- POC(Point of Care) 검사(POCT)
- 환자 자가 검사(PST)
- 임상 현장
시장의 매력 : 시험장소별

제10장 세계 시장 분석과 예측 : 최종사용자별

서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2020년-2034년
- 병원 및 진료소
- 진단 실험실
- 홈케어
- 공중위생 연구소
- 기타
시장의 매력 : 최종사용자별

제11장 세계 시장 분석과 예측 : 지역별

주요 조사 결과
시장 매출 예측 : 지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
시장의 매력 : 국가별, 지역별

제12장 북미 시장 분석과 예측

미국
캐나다

제13장 유럽 시장 분석과 예측

독일
영국
프랑스
이탈리아
스페인
기타 유럽

제14장 아시아태평양 시장 분석과 예측

중국
일본
인도
호주 및 뉴질랜드
기타 아시아태평양

제15장 라틴아메리카 시장 분석과 예측

브라질
멕시코
기타 라틴아메리카

제16장 중동 및 아프리카 시장 분석과 예측

GCC 국가
남아프리카공화국
기타 중동 및 아프리카

제17장 경쟁 구도

시장 기업 - 경쟁 매트릭스(기업 Tier과 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
- Abbott
- Becton, Dickinson, and Company(BD)
- bioMerieux SA
- Bio-Rad Laboratories, Inc
- Chembio Diagnostics, Inc.
- Danaher Corporation
- DiaSorin S.p.A.
- Roche Diagnostics(F. Hoffmann-La Roche AG)
- Fujirebio
- QuidelOrtho Corporation
- Shenzhen New Industries Biomedical Engineering Co., Ltd.
- Siemens Healthineers AG
- Sekisui Chemical Co Ltd
- Thermo Fisher Scientific, Inc.
- Trinity Biotech

LSH

영문 목차

영문목차

Syphilis Immunoassay Diagnostics Market - Scope of Report

TMR's report on the global syphilis immunoassay diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global syphilis immunoassay diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global syphilis immunoassay diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the syphilis immunoassay diagnostics market.

Market Snapshot
Market Value in 2023	US$ 548.5 Mn
Market Value in 2034	US$ 978.5 Mn
CAGR	5.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global syphilis immunoassay diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global syphilis immunoassay diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global syphilis immunoassay diagnostics market.

The report delves into the competitive landscape of the global syphilis immunoassay diagnostics market. Key players operating in the global syphilis immunoassay diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global syphilis immunoassay diagnostics market profiled in this report.

Key Questions Answered in Global syphilis immunoassay diagnostics Market Report:

What is the sales/revenue generated by syphilis immunoassay diagnostics across all regions during the forecast period?
What are the opportunities in the global syphilis immunoassay diagnostics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Syphilis Immunoassay Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global syphilis immunoassay diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global syphilis immunoassay diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global syphilis immunoassay diagnostics market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, 2020-2034
- 4.4.1. Market Revenue Projections (US$ Mn)
- 4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter's Five Force Analysis

5. Key Insights

5.1. Key Industry Events
5.2. Distributors Landscape
5.3. PORTER's Five Forces Analysis
5.4. End-user Preference
5.5. Epidemiology of Syphilis by Region/Countries
5.6. Government Initiatives by Region/Countries
5.7. Healthcare Expenditure by Region/Country (Health spending Total, US dollars/capita, 2022)
5.8. PESTEL Analysis
5.9. Impact of near patient testing and POC on syphilis market dynamics
5.10. Brand and Pricing Analysis
5.11. Regulatory Scenario by Region/ Country
5.12. Supply Chain Analysis
5.13. Technological Advancements

6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Product

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2020-2034
- 6.3.1. Analyzer
- 6.3.2. Kits & Reagents
6.4. Market Attractiveness By Product

7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Technology

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Technology, 2020-2034
- 7.3.1. Chemiluminescence Assay (CLIA)
- 7.3.2. Enzyme Linked Immunosorbent Assay (ELISA
- 7.3.3. Immunochromatographic Assay /Lateral Flow Assay
- 7.3.4. Treponema pallidum latex agglutination (TPLA)
- 7.3.5. Non-treponemal Flocculation Assay
7.4. Market Attractiveness By Technology

8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Test Type

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Test Type, 2020-2034
- 8.3.1. Treponemal Tests
- 8.3.2. Non-Treponemal Tests
8.4. Market Attractiveness By Test Type

9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Location of Testing

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Location of Testing, 2020-2034
- 9.3.1. Point-of-care testing (POCT)
- 9.3.2. Patient Self-Tests (PST)
- 9.3.3. Clinical Settings
9.4. Market Attractiveness By Location of Testing

10. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By End-user

10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By End-user, 2020-2034
- 10.3.1. Hospitals and Clinics
- 10.3.2. Diagnostics Laboratories
- 10.3.3. Home Care
- 10.3.4. Public Health Laboratory
- 10.3.5. Others
10.4. Market Attractiveness By End-user

11. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecasts, By Region

11.1. Key Findings
11.2. Market Value Forecast By Region
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
11.3. Market Attractiveness By Country/Region

12. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2020-2034
- 12.2.1. Analyzer
- 12.2.2. Kits & Reagents
12.3. Market Value Forecast By Technology, 2020-2034
- 12.3.1. Chemiluminescence Assay (CLIA)
- 12.3.2. Enzyme Linked Immunosorbent Assay (ELISA
- 12.3.3. Immunochromatographic Assay /Lateral Flow Assay
- 12.3.4. Treponema pallidum latex agglutination (TPLA)
- 12.3.5. Non-treponemal Flocculation Assay
12.4. Market Value Forecast By Test Type, 2020-2034
- 12.4.1. Treponemal Tests
- 12.4.2. Non-Treponemal Tests
12.5. Market Value Forecast By Location of Testing, 2020-2034
- 12.5.1. Point-of-care testing (POCT)
- 12.5.2. Patient Self-Tests (PST)
- 12.5.3. Clinical Settings
12.6. Market Value Forecast By End-user, 2020-2034
- 12.6.1. Hospitals and Clinics
- 12.6.2. Diagnostics Laboratories
- 12.6.3. Home Care
- 12.6.4. Public Health Laboratory
- 12.6.5. Others
12.7. Market Value Forecast By Country, 2020-2034
- 12.7.1. U.S.
- 12.7.2. Canada
12.8. Market Attractiveness Analysis
- 12.8.1. By Product
- 12.8.2. By Technology
- 12.8.3. By Test Type
- 12.8.4. By Location of Testing
- 12.8.5. By End-user
- 12.8.6. By Country

13. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2020-2034
- 13.2.1. Analyzer
- 13.2.2. Kits & Reagents
13.3. Market Value Forecast By Technology, 2020-2034
- 13.3.1. Chemiluminescence Assay (CLIA)
- 13.3.2. Enzyme Linked Immunosorbent Assay (ELISA
- 13.3.3. Immunochromatographic Assay /Lateral Flow Assay
- 13.3.4. Treponema pallidum latex agglutination (TPLA)
- 13.3.5. Non-treponemal Flocculation Assay
13.4. Market Value Forecast By Test Type, 2020-2034
- 13.4.1. Treponemal Tests
- 13.4.2. Non-Treponemal Tests
13.5. Market Value Forecast By Location of Testing, 2020-2034
- 13.5.1. Point-of-care testing (POCT)
- 13.5.2. Patient Self-Tests (PST)
- 13.5.3. Clinical Settings
13.6. Market Value Forecast By End-user, 2020-2034
- 13.6.1. Hospitals and Clinics
- 13.6.2. Diagnostics Laboratories
- 13.6.3. Home Care
- 13.6.4. Public Health Laboratory
- 13.6.5. Others
13.7. Market Value Forecast By Country, 2020-2034
- 13.7.1. Germany
- 13.7.2. U.K.
- 13.7.3. France
- 13.7.4. Italy
- 13.7.5. Spain
- 13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
- 13.8.1. By Product
- 13.8.2. By Technology
- 13.8.3. By Test Type
- 13.8.4. By Location of Testing
- 13.8.5. By End-user
- 13.8.6. By Country

14. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast By Product, 2020-2034
- 14.2.1. Analyzer
- 14.2.2. Kits & Reagents
14.3. Market Value Forecast By Technology, 2020-2034
- 14.3.1. Chemiluminescence Assay (CLIA)
- 14.3.2. Enzyme Linked Immunosorbent Assay (ELISA
- 14.3.3. Immunochromatographic Assay /Lateral Flow Assay
- 14.3.4. Treponema pallidum latex agglutination (TPLA)
- 14.3.5. Non-treponemal Flocculation Assay
14.4. Market Value Forecast By Test Type, 2020-2034
- 14.4.1. Treponemal Tests
- 14.4.2. Non-Treponemal Tests
14.5. Market Value Forecast By Location of Testing, 2020-2034
- 14.5.1. Point-of-care testing (POCT)
- 14.5.2. Patient Self-Tests (PST)
- 14.5.3. Clinical Settings
14.6. Market Value Forecast By End-user, 2020-2034
- 14.6.1. Hospitals and Clinics
- 14.6.2. Diagnostics Laboratories
- 14.6.3. Home Care
- 14.6.4. Public Health Laboratory
- 14.6.5. Others
14.7. Market Value Forecast By Country, 2020-2034
- 14.7.1. China
- 14.7.2. Japan
- 14.7.3. India
- 14.7.4. Australia & New Zealand
- 14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
- 14.8.1. By Product
- 14.8.2. By Technology
- 14.8.3. By Test Type
- 14.8.4. By Location of Testing
- 14.8.5. By End-user
- 14.8.6. By Country

15. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast By Product, 2020-2034
- 15.2.1. Analyzer
- 15.2.2. Kits & Reagents
15.3. Market Value Forecast By Technology, 2020-2034
- 15.3.1. Chemiluminescence Assay (CLIA)
- 15.3.2. Enzyme Linked Immunosorbent Assay (ELISA
- 15.3.3. Immunochromatographic Assay /Lateral Flow Assay
- 15.3.4. Treponema pallidum latex agglutination (TPLA)
- 15.3.5. Non-treponemal Flocculation Assay
15.4. Market Value Forecast By Test Type, 2020-2034
- 15.4.1. Treponemal Tests
- 15.4.2. Non-Treponemal Tests
15.5. Market Value Forecast By Location of Testing, 2020-2034
- 15.5.1. Point-of-care testing (POCT)
- 15.5.2. Patient Self-Tests (PST)
- 15.5.3. Clinical Settings
15.6. Market Value Forecast By End-user, 2020-2034
- 15.6.1. Hospitals and Clinics
- 15.6.2. Diagnostics Laboratories
- 15.6.3. Home Care
- 15.6.4. Public Health Laboratory
- 15.6.5. Others
15.7. Market Value Forecast By Country, 2020-2034
- 15.7.1. Brazil
- 15.7.2. Mexico
- 15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
- 15.8.1. By Product
- 15.8.2. By Technology
- 15.8.3. By Test Type
- 15.8.4. By Location of Testing
- 15.8.5. By End-user
- 15.8.6. By Country

16. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast

16.1. Introduction
- 16.1.1. Key Findings
16.2. Market Value Forecast By Product, 2020-2034
- 16.2.1. Analyzer
- 16.2.2. Kits & Reagents
16.3. Market Value Forecast By Technology, 2020-2034
- 16.3.1. Chemiluminescence Assay (CLIA)
- 16.3.2. Enzyme Linked Immunosorbent Assay (ELISA
- 16.3.3. Immunochromatographic Assay /Lateral Flow Assay
- 16.3.4. Treponema pallidum latex agglutination (TPLA)
- 16.3.5. Non-treponemal Flocculation Assay
16.4. Market Value Forecast By Test Type, 2020-2034
- 16.4.1. Treponemal Tests
- 16.4.2. Non-Treponemal Tests
16.5. Market Value Forecast By Location of Testing, 2020-2034
- 16.5.1. Point-of-care testing (POCT)
- 16.5.2. Patient Self-Tests (PST)
- 16.5.3. Clinical Settings
16.6. Market Value Forecast By End-user, 2020-2034
- 16.6.1. Hospitals and Clinics
- 16.6.2. Diagnostics Laboratories
- 16.6.3. Home Care
- 16.6.4. Public Health Laboratory
- 16.6.5. Others
16.7. Market Value Forecast By Country, 2020-2034
- 16.7.1. GCC Countries
- 16.7.2. South Africa
- 16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
- 16.8.1. By Product
- 16.8.2. By Technology
- 16.8.3. By Test Type
- 16.8.4. By Location of Testing
- 16.8.5. By End-user
- 16.8.6. By Country

17. Competition Landscape

17.1. Market Player - Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis, by Company (2023)
17.3. Company Profiles
- 17.3.1. Abbott
  - 17.3.1.1. Company Overview
  - 17.3.1.2. Financial Overview
  - 17.3.1.3. Product Portfolio
  - 17.3.1.4. Business Strategies
  - 17.3.1.5. Recent Developments
- 17.3.2. Becton, Dickinson, and Company (BD)
  - 17.3.2.1. Company Overview
  - 17.3.2.2. Financial Overview
  - 17.3.2.3. Product Portfolio
  - 17.3.2.4. Business Strategies
  - 17.3.2.5. Recent Developments
- 17.3.3. bioMerieux SA
  - 17.3.3.1. Company Overview
  - 17.3.3.2. Financial Overview
  - 17.3.3.3. Product Portfolio
  - 17.3.3.4. Business Strategies
  - 17.3.3.5. Recent Developments
- 17.3.4. Bio-Rad Laboratories, Inc
  - 17.3.4.1. Company Overview
  - 17.3.4.2. Financial Overview
  - 17.3.4.3. Product Portfolio
  - 17.3.4.4. Business Strategies
  - 17.3.4.5. Recent Developments
- 17.3.5. Chembio Diagnostics, Inc.
  - 17.3.5.1. Company Overview
  - 17.3.5.2. Financial Overview
  - 17.3.5.3. Product Portfolio
  - 17.3.5.4. Business Strategies
  - 17.3.5.5. Recent Developments
- 17.3.6. Danaher Corporation
  - 17.3.6.1. Company Overview
  - 17.3.6.2. Financial Overview
  - 17.3.6.3. Product Portfolio
  - 17.3.6.4. Business Strategies
  - 17.3.6.5. Recent Developments
- 17.3.7. DiaSorin S.p.A.
  - 17.3.7.1. Company Overview
  - 17.3.7.2. Financial Overview
  - 17.3.7.3. Product Portfolio
  - 17.3.7.4. Business Strategies
  - 17.3.7.5. Recent Developments
- 17.3.8. Roche Diagnostics (F. Hoffmann-La Roche AG)
  - 17.3.8.1. Company Overview
  - 17.3.8.2. Financial Overview
  - 17.3.8.3. Product Portfolio
  - 17.3.8.4. Business Strategies
  - 17.3.8.5. Recent Developments
- 17.3.9. Fujirebio
  - 17.3.9.1. Company Overview
  - 17.3.9.2. Financial Overview
  - 17.3.9.3. Product Portfolio
  - 17.3.9.4. Business Strategies
  - 17.3.9.5. Recent Developments
- 17.3.10. QuidelOrtho Corporation
  - 17.3.10.1. Company Overview
  - 17.3.10.2. Financial Overview
  - 17.3.10.3. Product Portfolio
  - 17.3.10.4. Business Strategies
  - 17.3.10.5. Recent Developments
- 17.3.11. Shenzhen New Industries Biomedical Engineering Co., Ltd.
  - 17.3.11.1. Company Overview
  - 17.3.11.2. Financial Overview
  - 17.3.11.3. Product Portfolio
  - 17.3.11.4. Business Strategies
  - 17.3.11.5. Recent Developments
- 17.3.12. Siemens Healthineers AG
  - 17.3.12.1. Company Overview
  - 17.3.12.2. Financial Overview
  - 17.3.12.3. Product Portfolio
  - 17.3.12.4. Business Strategies
  - 17.3.12.5. Recent Developments
- 17.3.13. Sekisui Chemical Co Ltd
  - 17.3.13.1. Company Overview
  - 17.3.13.2. Financial Overview
  - 17.3.13.3. Product Portfolio
  - 17.3.13.4. Business Strategies
  - 17.3.13.5. Recent Developments
- 17.3.14. Thermo Fisher Scientific, Inc.
  - 17.3.14.1. Company Overview
  - 17.3.14.2. Financial Overview
  - 17.3.14.3. Product Portfolio
  - 17.3.14.4. Business Strategies
  - 17.3.14.5. Recent Developments
- 17.3.15. Trinity Biotech
  - 17.3.15.1. Company Overview
  - 17.3.15.2. Financial Overview
  - 17.3.15.3. Product Portfolio
  - 17.3.15.4. Business Strategies
  - 17.3.15.5. Recent Developments